These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 190609
1. Gemfibrozil treatment: a comparison with clofibrate. Howard AN, Ghosh P. Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609 [Abstract] [Full Text] [Related]
2. A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias. Tuomilehto J, Salonen J, Kuuisto P, Virtamo J, Manninen V, Mälkönen M. Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):38-40. PubMed ID: 798195 [Abstract] [Full Text] [Related]
3. Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia. Olsson AG, Rössner S, Walldius G, Carlson LA. Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):28-31. PubMed ID: 190607 [Abstract] [Full Text] [Related]
4. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial. Eisalo A, Manninen V. Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196 [No Abstract] [Full Text] [Related]
5. The use of gemfibrozil in the treatment of primary hyperlipoproteinaemia. Preliminary report. Honorato J, Masso RM, Purroy A. Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):78-9. PubMed ID: 798200 [No Abstract] [Full Text] [Related]
6. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate. Nye ER, Sutherland WH, Temple Wa. N Z Med J; 1980 Nov 12; 92(671):345-9. PubMed ID: 6935550 [Abstract] [Full Text] [Related]
7. A long-term trial of gemfibrozil in the treatment of hyperlipidaemias. Eisalo A, Manninen V. Proc R Soc Med; 1976 Nov 12; 69 Suppl 2(Suppl 2):49-52. PubMed ID: 798198 [No Abstract] [Full Text] [Related]
8. Clofibrate and related compounds in hyperlipoproteinaemia. A review. Gustafson A. Postgrad Med J; 1975 Nov 12; 51(8):suppl 66-71. PubMed ID: 215983 [No Abstract] [Full Text] [Related]
9. Evaluation of increasing doses of gemfibrozil in hyperlipoproteinaemia. Lageder H, Irsigler K. Proc R Soc Med; 1976 Nov 12; 69 Suppl 2(Suppl 2):71-5. PubMed ID: 798199 [No Abstract] [Full Text] [Related]
10. CI-719 in hyperlipoproteinaemia: interim data. Bremner WF, Third JL, Clark B, Corstorphine C, Lawrie TD. Proc R Soc Med; 1976 Nov 12; 69 Suppl 2(Suppl 2):83-7. PubMed ID: 798201 [No Abstract] [Full Text] [Related]
11. The evaluation of lipoprotein changes during gemfibrozil treatment. Janus ED, Costa D, Ononogbu IC, Lewis B. Proc R Soc Med; 1976 Nov 12; 69 Suppl 2(Suppl 2):76-7. PubMed ID: 1019156 [Abstract] [Full Text] [Related]
16. Does hypolipidemic therapy prevent coronary heart disease? Rifkind BM, Levy RI. Cardiovasc Clin; 1974 Nov 12; 6(2):1-8. PubMed ID: 4374303 [No Abstract] [Full Text] [Related]
17. Extrinsic factors affecting the response to gemfibrozil. Huunan-Seppälä A, Manninen V, Burton R, Eisalo A. Proc R Soc Med; 1976 Nov 12; 69 Suppl 2(Suppl 2):53-7. PubMed ID: 1019154 [No Abstract] [Full Text] [Related]
18. Atilipidemic drugs. Part 5: Evaluation of the hypolipidemic effect of LF 178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV). Rouffy J, Dreux C, Goussault Y, Dakkak R, Renson FJ. Arzneimittelforschung; 1976 Nov 12; 26(5):901-6. PubMed ID: 183788 [Abstract] [Full Text] [Related]
19. Gemfibrozil in a group of diabetics. de Salcedo I, Gorringe AL, Silva JL, Santos JA. Proc R Soc Med; 1976 Nov 12; 69 Suppl 2(Suppl 2):64-70. PubMed ID: 1019155 [Abstract] [Full Text] [Related]
20. Effect of gemfibrozil on serum lipid levels. Dahlén G, Gillnäs T, Børresen AL, Berg K, Ericson C. Artery; 1980 Nov 12; 7(3):224-31. PubMed ID: 7008748 [Abstract] [Full Text] [Related] Page: [Next] [New Search]